Considering that radiotherapy is widely used in tumor treatment, whether reducing MDSCs migration by inhibiting CXCR2 and CCR2 signaling can promote the therapeutic effect of radiotherapy will be the focus of our subsequent study. Here, CXCR2 is linked to neoplasm.